510(k) K213875
K213875 is an FDA 510(k) premarket notification submitted by Microgenics Corporation for the device "DRI TM Tricyclics Serum Tox Assay". The FDA issued a decision of Substantially Equivalent on Dec 21, 2022. The device falls under product code LFH (U.V. Spectrometry, Tricyclic Antidepressant Drugs), a Class II device regulated under 21 CFR 862.3910. Microgenics Corporation has 20 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Dec 21, 2022
- Date Received
- Dec 13, 2021
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- U.V. Spectrometry, Tricyclic Antidepressant Drugs
- Device Class
- Class II
- Regulation Number
- 862.3910
- Review Panel
- TX
- Submission Type
- 510(k)
Need the full FDA record for Microgenics Corporation? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.